Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze BABAF stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BABAF investment potential.

What is BABAF stock price today?

Get real-time BABAF stock price, historical data, and price charts on Financhill. Track BABAF performance with our advanced analysis tools.

Is BABAF a good investment?

Evaluate BABAF investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BABAF stock?

To buy BABAF stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BABAF?

View detailed market capitalization data and company valuation metrics for BABAF on our comprehensive analysis page.

What is the P/E ratio of BABAF?

Use our fundamental analysis tools to view BABAF P/E ratio and compare valuation metrics with industry peers.

What are BABAF earnings?

View BABAF earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Alibaba Group Holding Ltd. 10K Form

Buy

BABAF
Alibaba Group Holding Ltd.

Last Price:

$20.55

Seasonality Move:

8.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BABAF News And Ratings

See the #1 stock for the next 7 days that we like better than BABAF

BABAF Financial Statistics

Sales & Book Value

Annual Sales:	$138B
Cash Flow:	$1.4B
Price / Cash Flow:	22.37
Annual Sales:	$8.08
Price / Book:	2.72

Profitability

EPS (TTM):	0.90780
Net Income (TTM):	$17.1B
Gross Margin:	$54.3B
Return on Equity:	11.27%
Return on Assets:	6.71%

Alibaba Group Holding Ltd. Earnings Forecast

Key Alibaba Group Holding Ltd. Financial Ratios

The Gross Profit Margin over the past 20 years for BABAF is 39.32%.
The Selling, General & Administrative Expenses for BABAF have been equal to 18.90% of Gross Profit Margin.
The Research & Development expenses have been 5.74% of Revenue.
The Interest Expense is 7.66% of Operating Income.
The Net Earning history of BABAF is 12.58% of Total Revenues.
Per Share Earnings over the last 20 years have been positive in 15 years.

Alibaba Group Holding Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	OTCM
Industry:	Broadline Retail
Sector:	Consumer Discretionary
Current Symbol:	BABAF
Website:	alibabagroup.com

Debt

Debt-to-Equity Ratio:	0.27
Current Ratio:	1.46
Quick Ratio:	0.93

Price-to-Earnings

Trailing P/E Ratio:	22.25
Forward P/E Ratio:	0

BABAF Technical Analysis vs Fundamental Analysis

Buy

Alibaba Group Holding Ltd. (BABAF) is a Buy

Is Alibaba Group Holding Ltd. a Buy or a Sell?

Alibaba Group Holding Ltd. stock is rated a Buy

The current Alibaba Group Holding Ltd. [BABAF] share price is $20.64. The Score for BABAF is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.